Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer: Real‐World Incidence and Concomitant Medication Effects
International Journal of Urology · 2026-04 · 33 (4)
DOI: 10.1111/iju.70448 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 30.03.2026. Verfasst von Asami Usui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Aminolevulinic Acid, Photosensitizing Agents, Non-Muscle Invasive Bladder Neoplasms, Dermatitis, Phototoxic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
The study quantifies the real‐world incidence of skin phototoxicity associated with oral 5‐aminolevulinic acid hydrochloride during photodynamic diagnosis‐assisted transurethral resection of bladder tumor. Furthermore, we assessed whether the Japanese regulatory revision in 2022 on the concomitant use with photosensitizing medications modified the risk.
Methods
We retrospectively analyzed 462 procedures performed at Toranomon Hospital between 2020 and 2024. The clinical data included demographics, laboratory results, medication history, and adverse reactions. Skin reactions were graded using the Common Terminology Criteria for Adverse Events, version 5.0. Logistic regression, including Firth's penalized likelihood, was used to identify independent predictors.
Results
Phototoxicity occurred in eleven procedures (all grade 1), and all patients recovered without complications. Skin phototoxicity occurred in one of 190 patients (0.5%) without photosensitizing agents and in 10 of 272 patients (3.7%) with the concomitant use of photosensitizing agents. The unadjusted relative risk was 7.0, and the absolute risk increase with photosensitizing drugs was 3.2% (number needed to harm, 32). Concomitant photosensitizing drugs and elevated preoperative alanine aminotransferase grade were independently associated with phototoxicity in univariate and multivariate analyses ( p < 0.05). The most frequently used concomitant medications included calcium‐channel blockers, angiotensin receptor blockers, statins, and thiazide diuretics.
Conclusions
Skin phototoxicity related to oral 5‐aminolevulinic acid hydrochloride during photodynamic diagnosis‐assisted transurethral resection of bladder tumor is uncommon and mild. Although the continued use of photosensitizing medications and elevated alanine aminotransferase levels increased the risk of phototoxicity, careful medication review and standard light‐avoidance measures can support the safe use of 5‐aminolevulinic acid hydrochloride.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Tomohiko Hara
Zitieren
APA
Usui, A., Hara, T., Oka, S., Sakaguchi, K., & Urakami, S. (2026). Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer: Real‐World Incidence and Concomitant Medication Effects. International Journal of Urology, 33(4). https://doi.org/10.1111/iju.70448
Vancouver
Usui A, Hara T, Oka S, Sakaguchi K, Urakami S. Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer: Real‐World Incidence and Concomitant Medication Effects. International Journal of Urology. 2026;33(4). doi:10.1111/iju.70448
BibTeX
@article{Usui2026,
author = {Usui, Asami and Hara, Tomohiko and Oka, Suguru and Sakaguchi, Kazushige and Urakami, Shinji},
title = {Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer: Real‐World Incidence and Concomitant Medication Effects},
journal = {International Journal of Urology},
year = {2026},
volume = {33},
number = {4},
doi = {10.1111/iju.70448}
}
EUVIMED